Term ends Jan 26, 2039 · High confidence
20-year base term ends Oct 31, 2038
Held by Allogene Therapeutics, Inc.
Filed Oct 31, 2018 as application 16/177,280 · Granted May 10, 2022
Base term plus 87 days of patent term adjustment (USPTO delay)
Today
2018
2039
Clock starts
Oct 31, 2018
Oct 31, 2018
Term ends
Jan 26, 2039
Jan 26, 2039
Granted
May 10, 2022
May 10, 2022
base term
patent term adjustment
fee events
Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
87
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
None
Terminal disclaimer
No disclaimer on this record.
1 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
3
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.
This patent's term runs 87 days past its 20-year base term on prosecution delay. 1 of 3 maintenance fees is paid so far. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Oct 31, 2018, when this application, 16/177,280, was filed | Oct 31, 2038 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | +87 days, USPTO patent term adjustment record | Jan 26, 2039 | High confidence |
| Terminal disclaimer cap | None on record | no cap applied | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 1 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Jan 26, 2039 | High confidence |
This family
| US 11,326,156 | this patent Jan 2039 | Jan 2039 |
| US 12,104,188 | In force Nov 2038 | Nov 2038 |
| US 12,790,603 | In force Jun 2039 | Jun 2039 |
The applications whose file history this site holds. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Jan 25, 2019 Reel 48142, frame 991 | Galindo Casas, Meritxell; Van Blarcom, Thomas John | Pfizer Inc. | Assignment of Assignor's Interest |
| Jan 25, 2019 Reel 48143, frame 18 | Pfizer Inc. | Allogene Therapeutics, Inc. | Assignment of Assignor's Interest |
| Jun 17, 2026 Reel 76575, frame 759 | Casas, Meritxell Galindo; Van Blarcom, Thomas John | Pfizer Inc. | Corrective Assignment to Correct the Year of the Execution Date on the Original Assignment Document for Inventor Thomas John Van Blarcom from 2018 to 2019. the Previously Recorded Cover Sheet Indicates the Correct Year of Inventors' Execution Date (2019), However the Previously Recorded Assignment Document Signed by Inventor Thomas John Van Blarcom Indicates the Incorrect Execution Year (2018). Previously Recorded on Reel 48142 Frame 991. Assignor(S) Hereby Confirms the Assignment of Assignor's Interest. |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
What's changing
Jan 2039
Term ends Jan 26, 2039. Maintenance fees still fall due before then
Note
The 87 days of patent term adjustment (USPTO delay) are read from the USPTO record, not recalculated by us
Citations
0
later US patents cite this one
That is below the median of utility patents granted in 2022 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.